Agenda – 3rd Payer Partnership Forum

  • Day One
  • Healthcare Executive Think Tank
  • Day Two

Day One

 

8:30AM – 8:45AM

Chairperson’s Opening Remarks
Marie Sanchirico, Medical Managed Care, SANOFI GENZYME

8:45AM – 9:30AM

Define Market Access As a Corporate Driver
Kathy Carlson, Senior Director, Patient Value and Access, Oncology Products, TAKEDA

9:30AM – 10:15AM

Importance of Companion Diagnostics Evidence for US and Global Coverage
Stephen Hull, Principal and Founder, Hull Associates LLC

10:15AM – 10:45AM

Uncover Best Practices for Innovative Contracting Between Pharma and Payers
Fred Brownfield, Former Director, Pharma Innovative Contracting, HUMANA

10:45AM – 11:00AM

Networking Break

11:00AM – 12:00PM

EXECUTIVE PAYER ASSEMBLY
Uncover Best Practices in Value-Based Contracting to Ensure Success From Initiation to Execution and Evaluation

Moderator
Marie Sanchirico, Director, Medical Managed Care, SANOFI GENZYME

Panelists
Fred Brownfield, Former Director, Pharma Innovative Contracting, HUMANA
Michael Ruiz, Vice President, Provider Relations, UCARE
Brian McGarry, Market President, AETNA
Pritpal Virdee, Senior Vice President and Chief Operating Officer, Senior Health Services, BLUE CROSS BLUE SHIELD MICHIGAN
Barrie Baker, M.D., MBA, Former Chief Medical Officer, TUFTS HEALTH PUBLIC PLANS
Jonathan Harding, M.D., Senior Medical Director, Senior Products Division, TUFTS HEALTH PLANS
Michael Kaminsky, Director, Value-Based Care Strategy, AETNA

12:00PM – 1:00PM

Networking Lunch

1:00PM – 1:45PM

Identify EU HTA Agencies’ Impact on U.S. Payers
Kris Thiruvillakkat, Director, Global Market Access Strategy, PFIZER

1:45PM – 2:30PM

Case Study: Abbott Nutrition’s Collaboration With Advocate Health Care From a Health Economics Perspective
Jamie Partridge, Director, Global Scientific Affairs, ABBOTT

2:30PM – 3:15PM

Value-Based Reimbursement: Legal and Strategic Considerations
Niall Brennan, President and Executive Director, HEALTH CARE COST INSTITUTE

3:15PM – 3:45PM

Networking Break

3:45PM – 4:45PM

Panel: Develop Value Propositions to Reflect Patient Needs
Moderator:
Adam Kundzewicz, Ph.D., Head of Strategic Market Access Initiatives, BOEHRINGER INGELHEIM

Panelists:
Sachin Kamal-Bahl, Vice President and Innovation Center Head, Global Health and Value, Pfizer
Lou Savant, Director of Market Access and Reimbursement, Osiris Therapeutics, Inc.
Diann Potestio, Senior Director Market Access, GENZYME


Healthcare Executive Think Tank

 

5:30PM – 6:00PM

Networking Drinks

6:00PM – 7:00PM

Dinner

7:00PM –

HEALTHCARE EXECUTIVE THINK TANK

As the healthcare landscape continues to drastically change and health systems continue to grow and consolidate to form large Accountable Care Organizations (ACOs) and Integrated Delivery Networks (IDNs), manufacturers are tasked with learning how to best contract with these expanding systems to ensure product success. With conflict of interest policies in place and restricted access to physicians, manufacturers need to change their sales approach.

This dinner panel is a unique opportunity to explore the needs of top ACO and IDN leaders in order to ensure you both thrive in the rapidly changing healthcare environment.

Moderator
Alan Gilbert, Chief Growth Officer, V3 HEALTHCARE STRATEGIES

Panelists
Mike Barrett, Founder, CURA HEALTH MANAGEMENT
Steven Peskin, Healthcare Delivery Innovation, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY
Sanjay Doddamani, Chief Medical Officer, GEISINGER LED KEYSTONE ACO
Anthony Vespa, Executive Director, SOUTHEAST MICHIGAN ACCOUNTABLE CARE
Michelle Copenhaver, SVP Strategy & Operations, Southeast Market Lead, Accountable Care Solutions, AETNA
John Minichiello, Executive Director, INTEGRA COMMUNITY CARE NETWORK ACO
Nicole Bradberry, CEO, FLORIDA ASSOCIATION OF ACOS
Marion Davis, CEO, PRIMARY PARTNERCARE


Day Two

 

8:30AM – 9:00AM

Continental Breakfast

9:00AM – 9:15AM

Chairperson’s Recap of Day One
Marie Sanchirico, Medical Managed Care, SANOFI GENZYME

9:15AM – 10:15AM

Define Strategies to Advance the Common Political and Structural Ground to Act As One Integrated Industry Instead of Insurers, Providers, and Pharma
Jeffrey Gold, Senior Vice President and Special Counsel, HEALTH ASSOCIATION OF NEW YORK STATE

10:15AM – 11:00AM

Considerations and Strategies in Developing Outcomes- Based Contracts
Josh Plumb, Senior Director, Distribution and Trade, SAGE THERAPEUTICS

11:00AM – 11:30AM

Networking Break

11:30AM – 12:15PM

Remove Communication Barriers to Engage Payer Stakeholders
Lance Hill, CEO, Within3

12:15PM – 1:15PM

Luncheon

1:15PM – 2:00PM

Examine What Is Right and What Is Wrong With Prescription Drug Pricing, Cost and Affordability in the United States
Robert Popovian, Pharm.D., Vice President, U.S. Government Relations, PFIZER

2:00PM – 3:00PM

From the Outside Looking In: A New Product Planning Perspective at Reimbursement and Pricing Early in Drug Development
Charles Pak, Senior Director, New Product Planning, IMMUNOGEN, INC.

3:00PM – 4:15PM

Use Real-World Evidence to Define and Demonstrate the Value Proposition
Anita Burrell, Adjunct Professor, RUTGERS UNIVERSITY

4:15PM – 4:30PM

Chairperson’s Closing Remarks
Marie Sanchirico, Medical Managed Care, SANOFI GENZYME

4:30PM –

Forum Concludes